These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 7397660)
1. Management of locally advanced and disseminated breast cancer--chemotherapy. Bisel HF Cancer; 1980 Aug; 46(4 Suppl):1079-83. PubMed ID: 7397660 [TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of recurrent breast cancer. Reimer RR Surg Clin North Am; 1978 Aug; 58(4):843-9. PubMed ID: 356302 [TBL] [Abstract][Full Text] [Related]
3. CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women. Salimtschik M; Snel S; Havsteen H; Dombernowsky P; Mouridsen HT Cancer Treat Rep; 1980; 64(4-5):635-7. PubMed ID: 7000346 [TBL] [Abstract][Full Text] [Related]
4. Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges. Lokich JJ; Moore CL; Anderson NR Cancer; 1996 Jul; 78(2):294-9. PubMed ID: 8674006 [TBL] [Abstract][Full Text] [Related]
5. Single and combination nonhormonal chemotherapy in breast cancer. Carter SK Cancer; 1972 Dec; 30(6):1543-55. PubMed ID: 4565817 [No Abstract] [Full Text] [Related]
6. [Comparative evaluation of the results of mono- and polychemotherapy of disseminated forms of breast cancer using the CMFVP program and anthracycline antibiotics (carminomycin and adriamycin)]. Trishkina EA; Gershanovich ML; Pavlov KA; Danova LA; Labkovskiĭ BM Antibiotiki; 1983 Nov; 28(11):853-8. PubMed ID: 6689116 [TBL] [Abstract][Full Text] [Related]
7. Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin. Creech RH; Catalano RB; Harris DT; Engstrom PF; Grotzinger PJ Cancer; 1979 Jan; 43(1):51-9. PubMed ID: 367574 [TBL] [Abstract][Full Text] [Related]
9. Antineoplastic chemotherapy. Mutz ID; Vietti TJ South Med J; 1977 Jul; 70(7):847-54. PubMed ID: 327567 [No Abstract] [Full Text] [Related]
10. [Treatment of advanced breast cancer with cyclophosphamide, methotrexate, 5-fluorouracil and prednisone (CMFP)]. Rabinovich MG; Leone BA; Landó O Medicina (B Aires); 1981; 41(1):65-70. PubMed ID: 7266359 [No Abstract] [Full Text] [Related]
11. Chemotherapy of advanced breast cancer. A general survey. Lyss AP; Loeb V Cancer; 1984 Feb; 53(3 Suppl):778-82. PubMed ID: 6546358 [TBL] [Abstract][Full Text] [Related]
12. Salvage chemotherapy for metastatic breast cancer. Hortobagyi GN Semin Hematol; 1987 Apr; 24(2 Suppl 1):56-61. PubMed ID: 3589709 [TBL] [Abstract][Full Text] [Related]
13. Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes. Shapiro CL; Gelman RS; Hayes DF; Osteen R; Obando A; Canellos GP; Frei E; Henderson IC J Natl Cancer Inst; 1993 May; 85(10):812-7. PubMed ID: 8487326 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. CMAJ; 1998 Feb; 158 Suppl 3():S52-64. PubMed ID: 9484279 [TBL] [Abstract][Full Text] [Related]
15. [Results of 5-fluorouracil, methotrexate, cyclophosphamide and prednisone combination therapy in the treatment of advanced breast cancer]. García Puche JL; Ballesteros P; Cueto J; Mendiola C; Rodríguez PA; Talavera MC Rev Clin Esp; 1979 Feb; 152(3):203-8. PubMed ID: 441472 [No Abstract] [Full Text] [Related]
16. Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer: a randomized trial. Muss HB; White DR; Richards F; Cooper MR; Stuart JJ; Jackson DV; Rhyne L; Spurr CL Cancer; 1978 Nov; 42(5):2141-8. PubMed ID: 363253 [TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of advanced breast cancer: a randomized trial of vincristine, Adriamycin, and cyclophosphamide (VAC) versus cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP). Carmo-Pereira J; Costa FO; Henriques E Cancer; 1981 Oct; 48(7):1517-21. PubMed ID: 7026020 [TBL] [Abstract][Full Text] [Related]
18. Comparison of four-combination chemotherapy programs in metastatic breast cancer: comparison of multiple drug therapy with cytoxan, 5-FU and prednisone versus cytoxan and adriamycin, versus cytoxan, 5-FU and adriamycin, versus cytoxan, 5-FU and prednisone alternating with cytoxan and adriamycin. Nemoto T; Horton J; Simon R; Dao TL; Rosner D; Cunningham T; Sponzo R; Snyderman M Cancer; 1982 May; 49(10):1988-93. PubMed ID: 7074523 [TBL] [Abstract][Full Text] [Related]
19. Comparison of induction chemotherapies for metastatic breast cancer. An Eastern Cooperative Oncology Group Trial. Tormey DC; Gelman R; Band PR; Sears M; Rosenthal SN; DeWys W; Perlia C; Rice MA Cancer; 1982 Oct; 50(7):1235-44. PubMed ID: 7049347 [TBL] [Abstract][Full Text] [Related]
20. Treatment of advanced breast cancer with cyclophosphamide, 5-fluorouracil, and prednisone with and without methanol-extracted residue of BCG. Britell JC; Ahmann DL; Bisel HF; Frytak S; Ingle JN; Rubin J; O'Fallon JR Cancer Clin Trials; 1979; 2(4):345-50. PubMed ID: 394870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]